Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia

被引：0
|
作者：
Gregory R. Mullen
Steven A. Kaplan
机构：
[1] Icahn School of Medicine at Mount Sinai,
来源：
Current Urology Reports | 2021年 / 22卷
关键词：
Urinary bladder; Overactive; Prostatic hyperplasia; Lower urinary tract symptoms; Mirabegron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia
    Mullen, Gregory R.
    Kaplan, Steven A.
    CURRENT UROLOGY REPORTS, 2021, 22 (01)
  • [2] Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS) REPLY
    不详
    JOURNAL OF UROLOGY, 2020, 203 (06) : 1171 - 1171
  • [3] Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study
    Kwon, Se Yun
    Park, Dong Jin
    Seo, Young Jin
    Lee, Kyung Seop
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 419 - 424
  • [4] Efficacy of mirabegron addition in benign prostatic hyperplasia with persistent overactive symptoms: a prospective study
    Kwon, S. Y.
    Lee, K. S.
    Kim, K. H.
    Seo, Y. J.
    Kang, Y. J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 119 - 120
  • [5] The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy A systematic review and meta-analysis
    Su, Shunye
    Lin, Jinlei
    Liang, Liqin
    Liu, Ludong
    Chen, Zhipeng
    Gao, Yuan
    MEDICINE, 2020, 99 (04)
  • [6] Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy
    Cai, Tong
    Wang, Ning
    Liang, Liye
    Zhou, Zhongbao
    Zhang, Yong
    Cui, Yuanshan
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2020, 24 (04) : 365 - 374
  • [7] β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men
    Hideo Otsuki
    Takeo Kosaka
    Kenzo Nakamura
    Junnji Mishima
    Yoshitaka Kuwahara
    Takuji Tsukamoto
    International Urology and Nephrology, 2013, 45 : 53 - 60
  • [8] Mirabegron in Overactive Bladder: A Review of Efficacy, Safety, and Tolerability
    Chapple, Christopher R.
    Cardozo, Linda
    Nitti, Victor W.
    Siddiqui, Emad
    Michel, Martin C.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 17 - 30
  • [9] β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men
    Otsuki, Hideo
    Kosaka, Takeo
    Nakamura, Kenzo
    Mishima, Junnji
    Kuwahara, Yoshitaka
    Tsukamoto, Takuji
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (01) : 53 - 60
  • [10] Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study
    Takahashi, Satoru
    Kato, Daisuke
    Tabuchi, Hiromi
    Uno, Satoshi
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2021, 13 (01) : 79 - 87
12345